Spinal Fusion Devices Market Share, Revenue, Top Players, Size, Trends, Overview by 2026

The global spinal fusion devices market is projected to reach USD 8.45 billion by 2026, exhibiting a CAGR of 3.6% during the forecast period. A rapidly rising global geriatric population will be a critical factor driving the growth of this market. According to the United Nations, around 16% of the world’s population will be over the age of 65 by 2050. In North America and Europe, close to 25% of the population will be aged. Aged people are highly vulnerable to various kinds of injuries and spinal cord injuries are one of the most common afflictions of old age. For instance, a study published in the Lancet journal showed that in the US, the average age of patients who suffered from spinal cord damage rose from 40 years to 50 years in just two decades. This shows that as geriatric population increases, the risk of spinal cord injuries also rises in tandem, thereby spiking the demand for spinal arthrodesis devices in the long-run.

Fortune Business Insights identifies some of the prominent competitors in this market:

• DePuy Synthes (Johnson & Johnson Services, Inc.)
• Aesculap, Inc. (B. Braun Melsungen AG)
• Stryker
• Alphatec Spine, Inc.
• RTI Surgical Holdings, Inc.
• Zimmer Biomet
• Medtronic
• NuVasive, Inc.

Growing Adoption of Surgical Robots for Spinal Injuries to Prove Favorable for the Market

There is an increasing demand for minimally invasive surgical procedures, prompting many hospitals to adopt robots for performing surgical procedures for the spinal treatments. As a result, manufacturers are now increasingly engaging in developing novel robotic technologies to aid surgeons perform tricky spinal cord surgeries with greater ease and accuracy. Thus, emergence of robotics in healthcare is, therefore, expected to shape the spinal fusion devices market trends during the forecast period.

Wide Availability of Opportunities to Innovate to Stimulate Competition

The spinal fusion devices market is set to receive a new influx of energy as competition in this market tightens. Major players are looking to gain momentum in this burgeoning market by increasing their investment in research to launch novel products and diversify their product portfolio.

Key industry developments include:

• August 2019: NuVasive, Inc. commercially launched its Modulus TLIF-A which is a porous titanium spinal implant designed to aid the transforaminal lumbar interbody fusion procedure. This will be the final installment in the company’s Advanced Materials Science product line aimed for all posterior interbody fusion techniques.
• July 2019: Alphatec Spine unveiled its titanium interbody implant system called IdentiTi. The device is engineered for performing anterior lumbar interbody fusion procedures.